Dublin, Ireland
Bristol-Myers Squibb will build a 323,000-sf biologics manufacturing facility in Dublin, Ireland. Located on the company's existing pharmaceutical production campus, the building will provide open labs and offices, six 15,000-liter bioreactors, and a purification area. The estimated construction cost of the project is $900 million. The facility will accommodate up to 400 employees and is expected to be fully operational in 2019.
